Published in Clin Rheumatol on March 31, 2015
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med (2017) 4.55
Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. J Clin Rheumatol (2015) 0.78
Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis. RMD Open (2016) 0.75
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23
Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum (1999) 2.41
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum (1990) 2.02
Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum (1998) 1.74
Meta-analysis of quality of life outcomes following diabetes self-management training. Diabetes Educ (2008) 1.43
Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum (2003) 1.21
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) (2010) 1.02
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken) (2012) 0.99
Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9. J Rheumatol (2009) 0.98
Illness perceptions and fatigue in systemic vasculitis. Arthritis Care Res (Hoboken) (2013) 0.86
A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am (2009) 0.86
MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis (2011) 0.86
Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis (2010) 0.81
Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis (2008) 0.80
Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms. J Rheumatol (2011) 0.80
Defining disease activity and damage in patients with small-vessel vasculitis. Cleve Clin J Med (2012) 0.77
Coping strategies and depressiveness in primary systemic vasculitis--what is their impact on health-related quality of life? Rheumatology (Oxford) (2013) 0.76